Assembly Biosciences Stock Price To Earnings To Growth
| ASMB Stock | USD 14.72 0.30 2.00% |
Assembly Biosciences fundamentals help investors to digest information that contributes to Assembly Biosciences' financial success or failures. It also enables traders to predict the movement of Assembly Stock. The fundamental analysis module provides a way to measure Assembly Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Assembly Biosciences stock.
Assembly | Price To Earnings To Growth |
Assembly Biosciences Company Price To Earnings To Growth Analysis
Assembly Biosciences' PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Assembly Price To Earnings To Growth Driver Correlations
Understanding the fundamental principles of building solid financial models for Assembly Biosciences is extremely important. It helps to project a fair market value of Assembly Stock properly, considering its historical fundamentals such as Price To Earnings To Growth. Since Assembly Biosciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Assembly Biosciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Assembly Biosciences' interrelated accounts and indicators.
Click cells to compare fundamentals
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Assembly Price Earnings To Growth Ratio
Price Earnings To Growth Ratio |
|
Based on the latest financial disclosure, Assembly Biosciences has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The price to earnings to growth for all United States stocks is 100.0% higher than that of the company.
Assembly Price To Earnings To Growth Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Assembly Biosciences' direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Assembly Biosciences could also be used in its relative valuation, which is a method of valuing Assembly Biosciences by comparing valuation metrics of similar companies.Assembly Biosciences is currently under evaluation in price to earnings to growth category among its peers.
Assembly Biosciences Current Valuation Drivers
We derive many important indicators used in calculating different scores of Assembly Biosciences from analyzing Assembly Biosciences' financial statements. These drivers represent accounts that assess Assembly Biosciences' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Assembly Biosciences' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 8.6B | 2.9B | 1.3B | 45.0M | 40.5M | 38.5M | |
| Enterprise Value | 8.6B | 2.8B | 1.3B | 27.5M | 24.8M | 23.5M |
Assembly Biosciences ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Assembly Biosciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Assembly Biosciences' managers, analysts, and investors.Environmental | Governance | Social |
Assembly Fundamentals
| Return On Equity | -1.02 | ||||
| Return On Asset | -0.35 | ||||
| Profit Margin | (2.12) % | ||||
| Operating Margin | (1.43) % | ||||
| Current Valuation | 1.96 M | ||||
| Shares Outstanding | 6.36 M | ||||
| Shares Owned By Insiders | 31.62 % | ||||
| Shares Owned By Institutions | 18.79 % | ||||
| Number Of Shares Shorted | 7.95 K | ||||
| Price To Earning | (10.58) X | ||||
| Price To Book | 3.67 X | ||||
| Price To Sales | 4.44 X | ||||
| Revenue | 7.16 M | ||||
| Gross Profit | (63.9 M) | ||||
| EBITDA | (64.2 M) | ||||
| Net Income | (61.23 M) | ||||
| Cash And Equivalents | 116.69 M | ||||
| Cash Per Share | 2.41 X | ||||
| Total Debt | 2.34 M | ||||
| Debt To Equity | 0.04 % | ||||
| Current Ratio | 8.31 X | ||||
| Book Value Per Share | 7.50 X | ||||
| Cash Flow From Operations | 22.74 M | ||||
| Short Ratio | 0.41 X | ||||
| Earnings Per Share | (6.89) X | ||||
| Target Price | 35.5 | ||||
| Number Of Employees | 65 | ||||
| Beta | 0.59 | ||||
| Market Capitalization | 95.47 M | ||||
| Total Asset | 137.47 M | ||||
| Retained Earnings | (785.75 M) | ||||
| Working Capital | 94.56 M | ||||
| Current Asset | 68.37 M | ||||
| Current Liabilities | 3.4 M | ||||
| Net Asset | 137.47 M |
About Assembly Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Assembly Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Assembly Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Assembly Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Assembly Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Assembly Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Assembly Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Assembly Biosciences Stock:Check out Assembly Biosciences Piotroski F Score and Assembly Biosciences Altman Z Score analysis. For information on how to trade Assembly Stock refer to our How to Trade Assembly Stock guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Assembly Biosciences. If investors know Assembly will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Assembly Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.89) | Revenue Per Share 4.125 | Quarterly Revenue Growth (1.00) | Return On Assets (0.35) | Return On Equity (1.02) |
The market value of Assembly Biosciences is measured differently than its book value, which is the value of Assembly that is recorded on the company's balance sheet. Investors also form their own opinion of Assembly Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Assembly Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Assembly Biosciences' market value can be influenced by many factors that don't directly affect Assembly Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Assembly Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Assembly Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Assembly Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.